276 related articles for article (PubMed ID: 3556994)
1. Biliary proteins and the nucleation defect in cholesterol cholelithiasis.
Gallinger S; Harvey PR; Petrunka CN; Ilson RG; Strasberg SM
Gastroenterology; 1987 Apr; 92(4):867-75. PubMed ID: 3556994
[TBL] [Abstract][Full Text] [Related]
2. Effects of a concanavalin A-binding biliary glycoprotein on nucleation time of gallbladder bile.
Nakano A; Masuzawa S; Ogura K; Fukazawa S; Nakamoto K; Sekido H; Fukushima T; Tsuchiya S
Gastroenterol Jpn; 1990 Feb; 25(1):88-92. PubMed ID: 2307338
[TBL] [Abstract][Full Text] [Related]
3. [Cholesterol crystals, cholesterol saturation of bile and biliary lithiasis].
Poupon R; Chrétien Y; Darnis F
Gastroenterol Clin Biol; 1984 Mar; 8(3):260-3. PubMed ID: 6714561
[TBL] [Abstract][Full Text] [Related]
4. Nucleation of cholesterol monohydrate crystals from hepatic and gall-bladder bile of patients with cholesterol gall stones.
Gollish SH; Burnstein MJ; Ilson RG; Petrunka CN; Strasberg SM
Gut; 1983 Sep; 24(9):836-44. PubMed ID: 6884818
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a potent nucleating factor in the gallbladder bile of patients with cholesterol gallstones.
Burnstein MJ; Ilson RG; Petrunka CN; Taylor RD; Strasberg SM
Gastroenterology; 1983 Oct; 85(4):801-7. PubMed ID: 6884705
[TBL] [Abstract][Full Text] [Related]
6. Isolation of a potent cholesterol nucleation-promoting activity from human gallbladder bile: role in the pathogenesis of gallstone disease.
Groen AK; Noordam C; Drapers JA; Egbers P; Jansen PL; Tytgat GN
Hepatology; 1990 Apr; 11(4):525-33. PubMed ID: 2328950
[TBL] [Abstract][Full Text] [Related]
7. Altered gallbladder concentration of biliary lipids during early cholesterol gallstone formation.
Roslyn JJ; Conter RL; DenBesten L
Dig Dis Sci; 1987 Jun; 32(6):609-14. PubMed ID: 3568948
[TBL] [Abstract][Full Text] [Related]
8. Quantification of cholesterol nucleation promoting activity in human gallbladder bile.
Drapers JA; Groen AK; Stout JP; Noordam C; Hoek FJ; Jansen PL; Tytgat GN
Clin Chim Acta; 1987 Jun; 165(2-3):295-302. PubMed ID: 3652451
[TBL] [Abstract][Full Text] [Related]
9. Reduced cholesterol metastability of hepatic bile and its further decline in gall bladder bile in patients with cholesterol gall stones.
Nakano K; Chijiiwa K
Gut; 1993 May; 34(5):702-7. PubMed ID: 8504975
[TBL] [Abstract][Full Text] [Related]
10. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones.
Jüngst D; Brenner G; Pratschke E; Paumgartner G
J Hepatol; 1989 Jan; 8(1):1-6. PubMed ID: 2921499
[TBL] [Abstract][Full Text] [Related]
11. Role of gallbladder mucin in pathophysiology of gallstones.
LaMont JT; Smith BF; Moore JR
Hepatology; 1984; 4(5 Suppl):51S-56S. PubMed ID: 6546237
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a nucleation defect in bile from gallstone patients.
Gallinger S; Harvey PR; Strasberg SM
Hepatology; 1984; 4(5 Suppl):177S-179S. PubMed ID: 6479877
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol and pigment gallstone disease: comparison of the reliability of three bile tests for differentiation between the two stone types.
van Erpecum KJ; van Berge Henegouwen GP; Stoelwinder B; Stolk MF; Eggink WF; Govaert WH
Scand J Gastroenterol; 1988 Oct; 23(8):948-54. PubMed ID: 3201132
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform.
Van Erpecum KJ; Van Berge-henegouwen GP; Eckhardt ER; Portincasa P; Van De Heijning BJ; Dallinga-Thie GM; Groen AK
Hepatology; 1998 Jun; 27(6):1508-16. PubMed ID: 9620320
[TBL] [Abstract][Full Text] [Related]
15. Hepatic bile versus gallbladder bile: a comparison of protein and lipid concentration and composition in cholesterol gallstone patients.
Keulemans YC; Mok KS; de Wit LT; Gouma DJ; Groen AK
Hepatology; 1998 Jul; 28(1):11-6. PubMed ID: 9657090
[TBL] [Abstract][Full Text] [Related]
16. Variations in pigment and carbohydrate content of gallbladder bile affect accurate quantitation of total protein when using the fluorescamine method.
Ginanni Corradini S; Yamashita G; Nuutinen H; Chernosky A; Williams C; Hays L; Shiffman ML; Walsh RM; Svanvik J; Della Guardia P; Capocaccia L; Holzbach RT
Scand J Gastroenterol; 1997 Apr; 32(4):340-9. PubMed ID: 9140156
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of gallstones.
Carey MC
Recenti Prog Med; 1992; 83(7-8):379-91. PubMed ID: 1529152
[TBL] [Abstract][Full Text] [Related]
18. Biliary nonmucin glycoproteins in patients with and without gallstones.
Lipsett PA; Fox-Talbot MK; Falconer SD; Tam ML; Magnuson TA; Lillemoe KD; Pitt HA
J Surg Res; 1995 Apr; 58(4):386-90. PubMed ID: 7723316
[TBL] [Abstract][Full Text] [Related]
19. Altered bile composition during cholesterol gallstone formation: cause or effect?
Magnuson TH; Lillemoe KD; Scheeres DE; Pitt HA
J Surg Res; 1990 Jun; 48(6):584-9. PubMed ID: 2362419
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones.
Jüngst D; Lang T; von Ritter C; Pratschke E; Paumgartner G
Hepatology; 1992 May; 15(5):804-8. PubMed ID: 1568721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
